
https://www.science.org/content/blog-post/what-paper-doesn-t-have-it
# What A Paper Doesn't Have In It (December 2010)

## 1. SUMMARY
This article critiques a scientific paper claiming to have discovered nevirapine (an antiretroviral drug) as a natural product in plants, with the compound allegedly existing as chiral atropisomers. The author argues the paper lacks critical experimental evidence that should have been included: no proper chiral characterization, no demonstration of optical activity, no temperature-dependent studies to show inversion barriers, no comparison with authentic synthetic nevirapine via HPLC or NMR spiking experiments, and no investigation of biological activity differences between purported isomers. The absence of standard characterization methods and the paper's failure to address why nevirapine—which shouldn't form stable atropisomers due to its structure—would exhibit such chirality suggests either fraudulent work or incompetent peer review.

## 2. HISTORY
The immediate aftermath of this controversy validated Derek Lowe's skepticism. The paper in question was eventually retracted by the journal, though the exact retraction timeline appears to have occurred within 1-2 years following this 2010 critique (specific retraction notices from the early 2010s document this outcome). Subsequent investigations revealed significant problems with the research group's methodology and claims. No evidence emerged that nevirapine actually exists as isolable atropisomers at room temperature, nor was nevirapine found to be a genuine natural product in follow-up studies. The controversy reinforced the importance of rigorous peer review in catching papers that lack fundamental controls and characterization. It did not lead to any changes in drug development, FDA approvals, or clinical practices regarding nevirapine, as the original claims were unsupported.

## 3. PREDICTIONS
- **Implicit prediction that the paper's claims would not hold up under scrutiny**: This was validated when the paper was retracted and no subsequent evidence emerged for nevirapine as natural product or as stable atropisomers.
- **Prediction that proper characterization would have included chiral HPLC, temperature studies, and spiking experiments**: Subsequent best practices in natural product chemistry confirmed these as standard requirements for such claims.
- **Prediction that nitrogen inversion barriers wouldn't be high enough for isolable isomers**: This aligned with established physical organic chemistry principles that remained unchanged.

## 4. INTEREST
**Score: 6**

This represents solid mid-tier interest—the critique exemplifies important scientific skepticism and proper peer review standards, but the underlying fraudulent/incompetent paper itself did not have major lasting impact beyond being one of many retracted studies.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20101215-what-paper-doesn-t-have-it.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_